Health Canada has updated its official List of Recognized Standards for Medical Devices, with an effective date of 2 November 2026. The revision adds 33 standards, updates technical recognition notes on 3 existing standards, and removes 9 entries relevant to declarations of conformity for new licences, licence amendments and applicable authorizations.
Under Health Canada's companion Guidance on using standards to support compliance with the Medical Devices Regulations, adherence to recognized standards remains voluntary—manufacturers may demonstrate compliance with the Medical Devices Regulations (SOR/98-282) using recognized standards or other evidence with adequate justification. Health Canada requires a Declaration of Conformity when a manufacturer relies on recognized standards.
Three Changes to Recognition Notes
Although Health Canada generally omits publication years and editions from main entries on the recognized list, each of the three updated entries has a recognition note. Two of those notes identify a specific edition:
- ISO 10993-1 (Biological evaluation within a risk management process): The note says devices subject to Clause 6.5.11.2 (Ed. 6, 2025) may need testing beyond that clause.
- CLSI EP25 (Evaluation of stability of in vitro medical laboratory test reagents): Health Canada excludes Section 7.1.2.3 (Ed. 2, 2023) from recognition.
- IEC 60601-2-24 (Infusion pumps and controllers): Health Canada points applicants to AAMI TIR101 for recommended fluid delivery performance testing and related labeling, consistent with its 2018 notice on Class II and III infusion pumps.
Pure Global analysis: Check the edition in your biological evaluation and whether Clause 6.5.11.2 applies before updating a declaration. The year in the note identifies the edition for that clause. The general edition rules below still apply to the undated list entry.
Thirty-Three Standards Added and Nine Removed
Health Canada's 2 November 2026 update expands recognized coverage across magnetic resonance safety, gas-pathway biocompatibility, surgical robotics, contact lens care, medical face masks, and replacement editions for older standards.
| Standard Domain | Newly Added Standards (33 Total) | Related Removals and Notes |
|---|---|---|
| MR safety & active implants | ASTM F2052, ASTM F2119, ASTM F2182, ASTM F2213, ASTM F2503, ISO/TS 10974 | Adds passive implant, medical device, and active implant MRI safety and marking standards |
| Breathing gas pathways | ISO 18562-1, ISO 18562-2, ISO 18562-3, ISO 18562-4 | Establishes gas-pathway particulate, VOC, and condensate leachables coverage |
| Medical electrical, monitoring & robotics | IEC 60601-1-12, IEC 60601-2-17, IEC 60601-2-83, IEC 80601-2-26, IEC 80601-2-49, IEC 80601-2-77 (surgical robots), ISO 80601-2-69, ISO 80601-2-85 | Removes IEC 60601-2-26, IEC 60601-2-49, and ISO 8359 (oxygen concentrators) |
| Orthopedics & dental | ASTM F3690 (suture anchors), ISO 21535 (hip), ISO 21536 (knee), ISO 9693 | Removes ASTM F2083 (knee) and ISO 9693-1 |
| Sterilization & masks | ISO 17665 (moist heat), ASTM F2100, EN 14683 | Removes ISO 17665-1 and ISO 14644-6 |
| Ophthalmic / contact lens care | ISO 9394, ISO 11981, ISO 11986, ISO 13212, ISO 14729, ISO 14730 | Adds physical compatibility, preservative uptake, shelf-life, and microbiological methods |
| IVD & blood pressure | CLSI EP35, ISO 81060-2 | Removes CLSI MM12 and CLSI MM16 |
Pure Global analysis: Use the table to identify where a removed standard and a new entry address a similar subject. For example, a knee implant file that cites ASTM F2083 can be reviewed against the scope of ISO 21536. Compare the actual editions and test methods before deciding whether the existing data support a declaration or whether more evidence is needed.
How the 3-Year Previous-Edition Rule Applies
Under Health Canada's standards guidance, when a standard appears on the recognized list without a specified year or edition, Health Canada recognizes both the latest published version and the previous version for 3 years from the date of publication of the latest version unless the latest standard sets a different transition period or Health Canada states otherwise in the list. Where the list specifies an edition or year, recognition applies to the specified version. Health Canada uses the date it receives the application to determine whether an edition is recognized.
Pure Global analysis: Manufacturers preparing upcoming Class II–IV MDL submissions or significant-change amendments should check four points before signing Declarations of Conformity under Health Canada rules:
- Audit removed and replaced series: Submissions still citing IEC 60601-2-26, IEC 60601-2-49, ISO 8359, ASTM F2083, ISO 9693-1, ISO 17665-1, CLSI MM12, CLSI MM16, or ISO 14644-6 need a new basis for any related declaration of conformity. Licences and authorizations already issued using a removed standard remain valid.
- Verify ISO 10993-1 Clause 6.5.11.2 and testing exclusions: For ISO 10993-1 (Ed. 6, 2025), assess whether additional testing is needed. Check the separate exclusions on the full list if the file also cites ISO 10993-10 or ISO 10993-23.
- Document CLSI EP25 and infusion-pump gaps: Assess how your IVD stability file supports any element affected by the CLSI EP25 exclusion. For infusion pumps, review the recommended AAMI TIR101 testing framework and corresponding labeling information.
- Record the edition before filing. Specify the edition in the application and Declaration of Conformity. If you plan to file near the end of a transition period, check the expected receipt date.











